Apaf-1 an activator of caspase-3
US6291643A · kind A · utility
27Cited by
23References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 5, 1998 |
| Grant date | Sep 18, 2001 |
| Priority date | — |
| Expiry date | Jun 5, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel polypeptides, designated Apaf-1, which are capable of modulating apoptosis are provided. Compositions including Apaf-1 chimeras, nucleic acid encoding Apaf-1, and antibodies to Apaf-1 are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.